Compliance is a concern for many manufacturers considering new technologies.
Tulip is currently CFR 21 Part 11 and Annex 11 compliant, and has the required audit trails for full GMP compliance.
Tulip is currently deployed on a Fortune 500 pharmaceutical drug production line in the final stages of validation. Tulip is also currently in full operation for a class III medical device (surgical implants) line.
If you’re curious how Tulip fits into your regulated manufacturing environment, get in touch to speak with an expert.